CSIMarket
 

Nuvasive Inc  (NASDAQ: NUVA)

Nuvasive Inc's

Competitiveness




 

NUVA Sales vs. its Competitors Q2 2023



Comparing the current results to its competitors, Nuvasive Inc reported Revenue increase in the 2 quarter 2023 by 2.36 % year on year.
The revenue growth was below Nuvasive Inc's competitors' average revenue growth of 7.75 %, achieved in the same quarter.

List of NUVA Competitors

With a net margin of 2.32 % Nuvasive Inc reported lower profitability than its competitors.

More on NUVA Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Nuvasive Inc achieved net profit of $7.36 millions compared to a net loss of $-0.89 millions recorded in the same quarter a year ago.

<<  NUVA Stock Performance Comparisons



  

Overall company Market Share Q2 2023

Overall company revenue, grew with moderate pace of 2.36 % slower than competitors within this segment.
<<  More on NUVA Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Nuvasive Inc




Jin Medical International Ltd
Share Performance



0.00%
Over The Past 5 Days



Jin Medical International Ltd
Profile

Jin Medical International Ltd. operates in the medical technology sector in China through a variable interest entity (VIE).

More about Jin Medical International Ltd's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 308.398 mill. $ 20.687 mill. $ 1.381 mill.


Procept Biorobotics Corporation
Share Performance



-50.98%
One Year



Procept Biorobotics Corporation
Profile

Procept Biorobotics Corporation follows a business model focused on developing medical robotics solutions for urology procedures. Their flagship product, the AquaBeam System, utilizes waterjet technology to perform minimally invasive surgeries for patients with benign prostatic hyperplasia. The company aims to improve patient outcomes and reduce healthcare costs by providing an innovative and efficient alternative to traditional surgical methods.

More about Procept Biorobotics Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,075.998 mill. $ 336.764 mill. $ -109.756 mill.


Pulse Biosciences Inc
Share Performance



+293.43%
This Year



Pulse Biosciences Inc
Profile

Pulse Biosciences Inc's business model focuses on the development and commercialization of proprietary technology platforms, specifically in the field of nano-pulse stimulation (NPS) technology.

More about Pulse Biosciences Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 3,645.457 mill. $ 1.185 mill. $ -80.056 mill.


Pro dex Inc
Share Performance



+9.09%
30 Days



Pro dex Inc
Profile

Pro dex Inc is a company that operates using a direct sales business model, selling their products directly to customers without the need for intermediaries. Their revenue is generated through the sales of their medical device components, primarily to original equipment manufacturers (OEMs) in the medical and dental industries. Pro dex Inc focuses on providing high-quality products and establishing long-term relationships with their customers to drive growth and profitability.

More about Pro dex Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 239.956 mill. $ 77.548 mill. $ 13.662 mill.


Prosomnus Inc
Share Performance



-90.96%
One Year



Prosomnus Inc
Profile

Prosomnus Inc's business model revolves around the development and manufacturing of advanced oral appliance solutions for sleep apnea treatment.

More about Prosomnus Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 8.175 mill. $ 32.387 mill. $ -29.848 mill.

36 more competitors available

Sign in to see all competitors

Sources: Nuvasive Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Nuvasive Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.